Published in Endocr Relat Cancer on December 01, 2011
Targeting the RAS oncogene. Expert Opin Ther Targets (2013) 1.02
Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo. BMC Cancer (2014) 0.91
K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis. Oncotarget (2015) 0.82
Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease. Pharmacol Ther (2016) 0.80
Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation. ACS Chem Biol (2014) 0.79
Targeting protein kinase C subtypes in pancreatic cancer. Expert Rev Anticancer Ther (2015) 0.78
A Rare Case of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. Case Rep Surg (2015) 0.75
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun (1994) 4.60
Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem (2002) 1.81
The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res (2007) 1.80
Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem (2000) 1.41
Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J Pharmacol Exp Ther (2007) 1.37
Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer (2003) 1.37
Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol (2003) 1.26
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors? Anticancer Drugs (2006) 1.17
Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas (1994) 1.17
Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors: progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms. Appl Immunohistochem Mol Morphol (2002) 1.15
Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion (2000) 1.14
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol (2001) 1.13
Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J Biol Chem (1996) 1.11
Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol (2005) 1.11
Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours. Eur J Surg Oncol (2002) 1.09
Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod Pathol (2005) 1.09
The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer (2005) 1.06
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res (2004) 1.05
Protein kinase C delta is required for survival of cells expressing activated p21RAS. J Biol Chem (2007) 1.04
Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.03
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab (2007) 1.02
Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab (2000) 1.02
Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol (1999) 1.00
Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment. Ann Oncol (1999) 0.99
BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors. Endocr Relat Cancer (2004) 0.97
Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene (1995) 0.96
Differential regulation of discrete apoptotic pathways by Ras. J Biol Chem (1998) 0.95
Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol (2000) 0.94
Isoform specificity of activators and inhibitors of protein kinase C gamma and delta. FEBS Lett (1997) 0.94
Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J Biol Chem (2000) 0.93
Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation. J Biol Chem (1991) 0.92
The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Cell Growth Differ (2001) 0.91
Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours. J Endocrinol (2003) 0.89
Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract. Expert Opin Pharmacother (2002) 0.89
PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1. Cell Signal (2008) 0.89
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target. Neuroendocrinology (2007) 0.87
BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumors. Am J Clin Pathol (2005) 0.87
Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol (2005) 0.87
An improved method for staining cell colonies in clonogenic assays. Cytotechnology (2007) 0.86
Selective inhibition of protein kinase C isozymes by Fas ligation. J Biol Chem (1999) 0.85
Calcium-dependent immediate-early gene induction in lymphocytes is negatively regulated by p21Ha-ras. Mol Cell Biol (1996) 0.85
Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell Death Differ (1998) 0.83
P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity. Mol Cell Biol (2002) 0.83
Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery (1992) 0.82
PKC-delta inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats. Basic Res Cardiol (2002) 0.80
Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines. J Cell Physiol (2004) 0.80
[Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.77
Cell type-specific differences in metabolic activation of N-nitrosodiethylamine by human lung cancer cell lines. IARC Sci Publ (1987) 0.77
v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction. J Biol Chem (1994) 0.77
Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. Chem Rev (2002) 2.43
Chemistry and biology of biosynthetic Diels-Alder reactions. Angew Chem Int Ed Engl (2003) 2.39
Notoamides A-D: prenylated indole alkaloids isolated from a marine-derived fungus, Aspergillus sp. Angew Chem Int Ed Engl (2007) 2.33
Isolation, structure elucidation, and biomimetic total synthesis of versicolamide B, and the isolation of antipodal (-)-stephacidin A and (+)-notoamide B from Aspergillus versicolor NRRL 35600. Angew Chem Int Ed Engl (2008) 2.06
A concise, biomimetic total synthesis of stephacidin A and notoamide B. Angew Chem Int Ed Engl (2007) 2.06
A concise total synthesis of the notoamides C and D. Angew Chem Int Ed Engl (2007) 1.86
Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor. J Am Chem Soc (2008) 1.64
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res (2006) 1.64
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood (2006) 1.57
Cytochrome p450 taxadiene 5alpha-hydroxylase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of taxol biosynthesis. Chem Biol (2004) 1.52
E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood (2003) 1.51
Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol (2007) 1.43
Retracted HIC1 regulates tumor cell responses to endocrine therapies. Mol Endocrinol (2009) 1.42
Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem J (2005) 1.38
Isolation of antipodal (-)-versicolamide B and notoamides L-N from a marine-derived Aspergillus sp. Org Lett (2009) 1.35
Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth. EMBO J (2002) 1.34
Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole. J Am Chem Soc (2009) 1.33
Isolation of notoamide E, a key precursor in the biosynthesis of prenylated indole alkaloids in a marine-derived fungus, Aspergillus sp. J Am Chem Soc (2009) 1.32
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J (2004) 1.29
Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood (2002) 1.26
Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem Biol (2011) 1.26
Concise, Biomimetic Total Synthesis of d,l-Marcfortine C. Tetrahedron (2007) 1.25
Synthetic Studies on the Ambiguine Family of Alkaloids: Construction of the ABCD Ring System. Tetrahedron Lett (2011) 1.25
Improved biomimetic total synthesis of D,L-stephacidin A. Org Lett (2007) 1.25
Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci (2010) 1.24
Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold. Org Lett (2009) 1.23
Asymmetric total syntheses of (+)- and (-)-versicolamide B and biosynthetic implications. Nat Chem (2009) 1.22
Genome-based characterization of two prenylation steps in the assembly of the stephacidin and notoamide anticancer agents in a marine-derived Aspergillus sp. J Am Chem Soc (2010) 1.22
Concise, asymmetric total synthesis of spirotryprostatin A. Org Lett (2003) 1.21
Enantiomeric natural products: occurrence and biogenesis. Angew Chem Int Ed Engl (2012) 1.19
Fungal origins of the bicyclo[2.2.2]diazaoctane ring system of prenylated indole alkaloids. J Nat Prod (2012) 1.19
Asymmetric total synthesis of (-)-VM55599: establishment of the absolute stereochemistry and biogenetic implications. J Am Chem Soc (2002) 1.16
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res (2011) 1.15
Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood (2006) 1.15
Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. Bioorg Med Chem Lett (2006) 1.14
Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Carcinogenesis (2008) 1.12
Taxus metabolomics: methyl jasmonate preferentially induces production of taxoids oxygenated at C-13 in Taxus x media cell cultures. Phytochemistry (2003) 1.12
Biomimetic total synthesis of malbrancheamide and malbrancheamide B. J Org Chem (2008) 1.12
Studies on the biosynthesis of paraherquamide A and VM99955. A theoretical study of intramolecular Diels-Alder cycloaddition. J Org Chem (2003) 1.12
Synthetic approaches to the bicyclo[2.2.2]diazaoctane ring system common to the paraherquamides, stephacidins and related prenylated indole alkaloids. Chem Soc Rev (2009) 1.10
Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets (2003) 1.10
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood (2011) 1.09
Concise, asymmetric, stereocontrolled total synthesis of stephacidins A, B and notoamide B. J Am Chem Soc (2007) 1.08
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J Biol Chem (2006) 1.08
Asymmetric total syntheses of (-)-jorumycin, (-)-renieramycin G, 3-epi-jorumycin, and 3-epi-renieramycin G. J Am Chem Soc (2005) 1.07
Biochemical characterization of NotB as an FAD-dependent oxidase in the biosynthesis of notoamide indole alkaloids. J Am Chem Soc (2011) 1.06
Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors. Nat Prod Rep (2009) 1.06
Synthetic studies on quinine: quinuclidine construction via a ketone enolate regio- and diastereoselective Pd-mediated allylic alkylation. Org Lett (2006) 1.06
Medical hyperspectral imaging to facilitate residual tumor identification during surgery. Cancer Biol Ther (2007) 1.05
Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J Biol Chem (2002) 1.05
Premalbrancheamide: synthesis, isotopic labeling, biosynthetic incorporation, and detection in cultures of Malbranchea aurantiaca. Org Lett (2008) 1.04
Protein kinase C delta is required for survival of cells expressing activated p21RAS. J Biol Chem (2007) 1.04
Taxoid metabolism: Taxoid 14beta-hydroxylase is a cytochrome P450-dependent monooxygenase. Arch Biochem Biophys (2003) 1.03
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive. Cell Growth Differ (2002) 1.03
Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives. Blood Cells Mol Dis (2005) 1.03
Comparative analysis of the biosynthetic systems for fungal bicyclo[2.2.2]diazaoctane indole alkaloids: the (+)/(-)-notoamide, paraherquamide and malbrancheamide pathways. Medchemcomm (2012) 1.02
Targeting the RAS oncogene. Expert Opin Ther Targets (2013) 1.02
STUDIES ON THE BIOSYNTHESIS OF THE STEPHACIDINS AND NOTOAMIDES. TOTAL SYNTHESIS OF NOTOAMIDE S. Heterocycles (2010) 1.01
SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells. Prostate (2012) 1.00
A concise, total synthesis of the TMC-95A/B proteasome inhibitors. Proc Natl Acad Sci U S A (2004) 1.00
Biosynthetic studies of the notoamides: isotopic synthesis of stephacidin A and incorporation into notoamide B and sclerotiamide. Org Lett (2011) 1.00
A concise total synthesis of (+)-FR900482 and (+)-FR66979. J Org Chem (2004) 0.99
Molecular analysis of a 4-dimethylallyltryptophan synthase from Malbranchea aurantiaca. J Biol Chem (2008) 0.98
SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol (2013) 0.98
Concise enantioselective synthesis of (+)-FR66979 and (+)-FR900482: dimethyldioxirane-mediated construction of the hydroxylamine hemiketal. Angew Chem Int Ed Engl (2002) 0.97
Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome. Chem Biol (2002) 0.96
Asymmetric synthesis of (2S,3R)-capreomycidine and the total synthesis of capreomycin IB. J Am Chem Soc (2003) 0.95
Fetal globin gene inducers: novel agents and new potential. Ann N Y Acad Sci (2010) 0.95
A concise asymmetric synthesis of the ADE fragment of nakadomarin A. Org Lett (2004) 0.94
Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma. Am J Pathol (2009) 0.94
Synthetic Studies on Palau'amine. Construction of the Cyclopentane Core via an Asymmetric 1,3-Dipolar Cycloaddition. Tetrahedron Lett (2010) 0.93
Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives. Eur J Haematol (2009) 0.93
Synthesis of notoamide J: a potentially pivotal intermediate in the biosynthesis of several prenylated indole alkaloids. J Org Chem (2010) 0.93
Transcription Regulation by Class III Histone Deacetylases (HDACs)-Sirtuins. Transl Oncogenomics (2008) 0.93
Studies on the biosynthesis of the notoamides: synthesis of an isotopomer of 6-hydroxydeoxybrevianamide E and biosynthetic incorporation into notoamide J. J Org Chem (2011) 0.93
Asymmetric total synthesis of (-)-cribrostatin 4 (renieramycin H). Angew Chem Int Ed Engl (2007) 0.92
Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo. BMC Cancer (2014) 0.91
The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites. Nat Prod Rep (2012) 0.91
Administering cultured Taxus cells with early precursors reveals bifurcations in the taxoid biosynthetic pathway. Phytochemistry (2006) 0.91
Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology (2002) 0.91
Drosophila female sterile (1) homeotic is a multifunctional transcriptional regulator that is modulated by Ras signaling. Dev Dyn (2008) 0.91
Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide. FEBS Lett (2007) 0.91
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Anticancer Drugs (2008) 0.90
Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol (2005) 0.90
Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther (2007) 0.90
Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228). Org Lett (2008) 0.90
Butyrate histone deacetylase inhibitors. Biores Open Access (2012) 0.90
Synthetic and biosynthetic studies on FR900482 and mitomycin C: an efficient and stereoselective hydroxymethylation of an advanced benzazocane intermediate. Org Lett (2007) 0.89
Studies on taxol biosynthesis. Preparation of taxa-4(20),11(12)-dien-5 alpha-acetoxy-10 beta-ol by deoxygenation of a taxadiene tetraacetate obtained from Japanese yew. J Org Chem (2002) 0.89
PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1. Cell Signal (2008) 0.89